Raymond James Financial
NVAX icon

Raymond James Financial’s Novavax NVAX Stock Holding History

Raymond James Financial’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.1M Buy
117,029
+25,395
+28% +$228K ﹤0.01% 3931
2026
Q1 		$746K Buy
91,634
+7,564
+9% +$68.6K ﹤0.01% 4074
2025
Q4 		$565K Sell
84,070
-3,436
-4% -$25.9K ﹤0.01% 4175
2025
Q3 		$759K Sell
87,506
-34,738
-28% -$270K ﹤0.01% 3860
2025
Q2 		$770K Buy
122,244
+60,438
+98% +$400K ﹤0.01% 3739
2025
Q1 		$396K Sell
61,806
-5,838
-9% -$48.3K ﹤0.01% 4069
2024
Q4 		$544K Buy
+67,644
New +$652K ﹤0.01% 3855

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Raymond James Financial's NVAX Position: Q2 2026 in Review

Raymond James Financial increased its Novavax (NVAX) stake by 28% in Q2 2026, buying an estimated $228K and bringing the position to 117,029 shares worth $1.1M. The position accounts for ﹤0.01% of the portfolio, ranked #3931.

Raymond James Financial first reported a position in NVAX in Q4 2024 and has held it in 7 quarters since. 267 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Raymond James Financial held 117,029 shares of Novavax worth $1.1M as of Q2 2026.
  • Raymond James Financial bought 25,395 Novavax shares in Q2 2026, an estimated $228K.
  • Novavax made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #3931 holding.
  • Raymond James Financial first reported a position in Novavax in Q4 2024 and has held it in 7 quarters since.
  • 267 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.